Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,187 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,187 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,187 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,187 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,187 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,187 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,187 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
8 Jan 2026
Eric Pauwels Chief Business Officer
Sold on a plan 3×
$352.06K 4,602 at 76.50
5.3%
Planned (10b5-1)
8 Jan 2026
Laura A Williams Chief Patient Officer
Sold on a plan
$348.90K 50,000 at 6.98
12.1%
Planned (10b5-1)
8 Jan 2026
Jacob DeWitte Co-Founder, CEO · indirect also filed by Caroline Cochran
Sold on a plan 3×
$345.54K 3,455 at 100.01
0.4%
Planned (10b5-1)
8 Jan 2026
Mark Elliott Boulding Exec. VP and CLO
Sold on a plan 3×
$308.76K 4,033 at 76.56
3.4%
Planned (10b5-1)
8 Jan 2026
Corey J Manley EVP&Chief Legal/Admin Officer
Sold on a plan
$304.69K 6,106 at 49.90
6.2%
Planned (10b5-1)
8 Jan 2026
Stuart A Tross Chief People & Workpl Officer
Sold on a plan
$297.55K 47,006 at 6.33
4.6%
Planned (10b5-1)
8 Jan 2026
Michael S Williams Chief Executive Officer
Sold on a plan
$276.22K 14,462 at 19.10
2.0%
Planned (10b5-1)
8 Jan 2026
Matt Mills President
Sold on a plan
$269.51K 13,771 at 19.57
0.7%
Planned (10b5-1)
8 Jan 2026
Stephen J Altemus Chief Executive Officer
Sold on a plan
$253.42K 12,669 at 20.00
1.2%
Planned (10b5-1)
8 Jan 2026
Richard A. Heyman Director · indirect
Sold on a plan 2×
$241.16K 9,635 at 25.03
27.4%
Planned (10b5-1)
8 Jan 2026
Michael L. Perica EVP & Chief Financial Officer
Sold on a plan
$215.53K 53,882 at 4.00
36.9%
Planned (10b5-1)
8 Jan 2026
Leslie Norwalk V Director
Sold on a plan
$202.20K 2,000 at 101.10
16.1%
Planned (10b5-1)
8 Jan 2026
Mark S. Garfield Chief Accounting Officer
Sold on a plan
$199.71K 953 at 209.56
2.6%
Planned (10b5-1)
8 Jan 2026
Matthew B. Klein Chief Executive Officer
Sold on a plan
$192.20K 2,514 at 76.45
0.6%
Planned (10b5-1)
8 Jan 2026
Amit Dhingra Chief Enterprise Pmts Officer
Sold on a plan
$185.00K 10,000 at 18.50
6.0%
Planned (10b5-1)
8 Jan 2026
John C Watts EVP & Chief Growth Officer
Sold on a plan
$172.80K 288 at 600.00
8.3%
Planned (10b5-1)
8 Jan 2026
Jesse Timmermans Chief Financial Officer
Sold on a plan
$168.55K 5,349 at 31.51
31.5%
Planned (10b5-1)
8 Jan 2026
Craig C. Hopkinson EVP R&D, Chief Medical Officer
Sold on a plan
$150.01K 5,000 at 30.00
7.5%
Planned (10b5-1)
8 Jan 2026
Jacob DeWitte Co-Founder, CEO also filed by Caroline Cochran
Sold on a plan
$125.50K 1,255 at 100.00
0.2%
Planned (10b5-1)
8 Jan 2026
Kevin McCulloch See Remarks
Sold on a plan
$120.00K 15,000 at 8.00
0.9%
Planned (10b5-1)
8 Jan 2026
Adam B Frankel General Counsel
Sold on a plan
$119.57K 4,382 at 27.29
2.0%
Planned (10b5-1)
8 Jan 2026
Timothy Price Crain II SVP and Chief Growth Officer
Sold on a plan
$113.22K 5,660 at 20.00
1.9%
Planned (10b5-1)
8 Jan 2026
James Labe Chief Executive Officer · indirect also filed by Sajal Srivastava
Bought on a plan
$111.20K 16,833 at 6.61
0.9%
Bought on a plan
8 Jan 2026
Joseph Oliveto President and CEO
Sold on a plan
$96.75K 43,000 at 2.25
12.4%
Planned (10b5-1)
8 Jan 2026
Christopher Schmitt General Counsel and Secretary
Sold on a plan
$88.21K 4,507 at 19.57
0.4%
Planned (10b5-1)
8 Jan 2026
Chandrasekar Gnanasambandam EVP Product & CTO
Sold on a plan
$83.08K 4,245 at 19.57
0.8%
Planned (10b5-1)
8 Jan 2026
Christine Marie Utter SVP, Chief Accounting Officer
Sold on a plan
$79.05K 1,034 at 76.45
1.4%
Planned (10b5-1)
8 Jan 2026
Brian Read Chief Financial Officer
Sold on a plan 2×
$75.05K 4,748 at 15.81
1.4%
Planned (10b5-1)
8 Jan 2026
Mitra Rezvan Chief Accounting Officer
Sold on a plan
$74.02K 3,782 at 19.57
3.1%
Planned (10b5-1)
8 Jan 2026
Abby Payne Chief People Officer
Sold on a plan
$70.10K 3,582 at 19.57
0.5%
Planned (10b5-1)
8 Jan 2026
Neil Gregory Almstead Chief Technical Ops Officer
Sold on a plan
$67.35K 881 at 76.45
0.8%
Planned (10b5-1)
8 Jan 2026
Lee Scott Golden EVP & Chief Medical Officer
Sold on a plan
$66.21K 866 at 76.45
0.9%
Planned (10b5-1)
8 Jan 2026
Matthew Rizik Director
Sold on a plan
$53.21K 2,500 at 21.29
0.2%
Planned (10b5-1)
8 Jan 2026
Matthijs Glastra Chief Executive Officer
Sold on a plan
$42.04K 323 at 130.14
0.4%
Planned (10b5-1)
8 Jan 2026
Randall Moreadith Chief Scientific Officer
Sold on a plan
$34.95K 13,000 at 2.69
100%
Sold half or more
8 Jan 2026
Ian H. Siegel Chief Executive Officer · indirect
Sold on a plan
$32.84K 9,722 at 3.38
13.4%
Planned (10b5-1)
8 Jan 2026
Deanna D Strable-Soethout President and CEO · indirect
Sold on a plan
$27.75K 300 at 92.50
0.5%
Planned (10b5-1)
8 Jan 2026
Amber Fairbanks EVP, Property Management
Sold on a plan
$24.97K 185 at 134.98
5.0%
Planned (10b5-1)
8 Jan 2026
Melanie Carpenter EVP & CHRO
Sold on a plan
$19.57K 145 at 134.98
0.7%
Planned (10b5-1)
8 Jan 2026
Enrique Pizzi Chief Information Officer
Sold on a plan
$13.47K 1,825 at 7.38
2.1%
Planned (10b5-1)
8 Jan 2026
Sold on a plan
$9.85K 73 at 134.98
0.7%
Planned (10b5-1)
8 Jan 2026
Penny Tom Principal Accounting Officer
Sold on a plan
$8.43K 6,533 at 1.29
100%
Sold half or more
8 Jan 2026
Timothy Argo EVP, Chief Strategy & Analysis
Sold on a plan
$7.15K 53 at 134.98
0.3%
Planned (10b5-1)
8 Jan 2026
Yvonne Hui Principal Accounting Officer
Sold on a plan
$6.50K 372 at 17.47
1.2%
Planned (10b5-1)
8 Jan 2026
Luke Evnin Director · indirect
Sold on a plan
$4.86K 7,716 at 0.63
0.3%
Planned (10b5-1)
8 Jan 2026
Neil Gregory Almstead Chief Technical Ops Officer · indirect
Sold on a plan
$4.51K 59 at 76.45
0.9%
Planned (10b5-1)
8 Jan 2026
Thomas J Pernice Director
Sold on a plan
no price 25,000 shares
9.3%
Planned (10b5-1)
Showing 18,901–18,950 of 23,187. ← Newer Page 379 of 464 Older →